Multiple linear regression applied to predicting droplet size of complex perfluorocarbon nanoemulsions for biomedical applications

References

• Amani A, York P, Chrystyn H, Clark BJ. 2010. Factors affecting the stability of nanoemulsions—use of artificial neural networks. Pharm Res. 27:37.
   PubMed Web of Science ®Google Scholar
• Aqil M, Kamran M, Ahad A, Imam SS. 2016. Development of clove oil based nanoemulsion of olmesartan for transdermal delivery: Box–Behnken design optimization and pharmacokinetic evaluation. J Mol Liq. 214:238–248.
   Web of Science ®Google Scholar
• Balducci A, Wen Y, Zhang Y, Helfer BM, Hitchens TK, Meng WS, Wesa AK, Janjic JM. 2013. A novel probe for the non-invasive detection of tumor-associated inflammation. Oncoimmunology. 2:e23034.
   PubMed Web of Science ®Google Scholar
• Boissenot T, Fattal E, Bordat A, Houvenagel S, Valette J, Chacun H, Gueutin C, Tsapis N. 2016. Paclitaxel-loaded PEGylated nanocapsules of perfluorooctyl bromide as theranostic agents. Eur J Pharm Biopharm. 108:136–144.
   PubMed Web of Science ®Google Scholar
• Challenge and Opportunity on the Critical Path to New Medical Products. 2004. U.S. Food and Drug Administration; [accessed 2018 Apr 26]. http://wayback.archive-it.org/7993/20180125035500/https://www.fda.gov/downloads/ScienceResearch/SpecialTopics/CriticalPathInitiative/CriticalPathOpportunitiesReports/UCM113411.pdf.
   Google Scholar
• Chen X. 2011. Introducing Theranostics Journal - From the Editor-in-Chief. Theranostics. 1:1–2.
   PubMed Web of Science ®Google Scholar
• Critical Path Opportunities Initiated During 2006. 2006. [accessed 2018 Apr 26]. http://wayback.archive-it.org/7993/20180125142843/https://www.fda.gov/ScienceResearch/SpecialTopics/CriticalPathInitiative/CriticalPathOpportunitiesReports/ucm077251.htm.
   Google Scholar
• Cyrus T, Zhang H, Allen JS, Williams TA, Hu G, Caruthers SD, Wickline SA, Lanza GM. 2008. Intramural delivery of rapamycin with alphavbeta3-targeted paramagnetic nanoparticles inhibits stenosis after balloon injury. Arterioscler Thromb Vasc Biol. 28:820–826.
   PubMed Web of Science ®Google Scholar
• Davis SS, Round HP, Purewal TS. 1981. Ostwald ripening and the stability of emulsion systems: an explanation for the effect of an added third component. J Colloid Interface Sci. 80:508–511.
   Web of Science ®Google Scholar
• Dewitte H, Geers B, Liang S, Himmelreich U, Demeester J, De Smedt SC, Lentacker I. 2013. Design and evaluation of theranostic perfluorocarbon particles for simultaneous antigen-loading and 19F-MRI tracking of dendritic cells. J Control Release. 169:141–149.
   PubMed Web of Science ®Google Scholar
• Epa VC, Burden FR, Tassa C, Weissleder R, Shaw S, Winkler DA. 2012. Modeling biological activities of nanoparticles. Nano Lett. 12:5808–5812.
   PubMed Web of Science ®Google Scholar
• Eriksson L, Johansson E, Wikström C. 1998. Mixture design—design generation, PLS analysis, and model usage. Chemometr Intell Lab Syst. 43:1–24.
   Web of Science ®Google Scholar
• Fraker CA, Mendez AJ, Inverardi L, Ricordi C, Stabler CL. 2012. Optimization of perfluoro nano-scale emulsions: the importance of particle size for enhanced oxygen transfer in biomedical applications. Colloids Surf B Biointerfaces. 98:26–35.
   PubMed Web of Science ®Google Scholar
• Freire MG, Dias AMA, Coelho MAZ, Coutinho JAP, Marrucho IM. 2005. Aging mechanisms of perfluorocarbon emulsions using image analysis. J Colloid Interface Sci. 286:224–232.
   PubMed Web of Science ®Google Scholar
• Grapentin C, Barnert S, Schubert R. 2015. Monitoring the stability of perfluorocarbon nanoemulsions by Cryo-TEM image analysis and dynamic light scattering. PLoS One. 10:e0130674.
   PubMed Web of Science ®Google Scholar
• Hannah A, Luke G, Wilson K, Homan K, Emelianov S. 2014. Indocyanine green-loaded photoacoustic nanodroplets: dual contrast nanoconstructs for enhanced photoacoustic and ultrasound imaging. ACS Nano. 8:250–259.
   PubMed Web of Science ®Google Scholar
• He C, Hu Y, Yin L, Tang C, Yin C. 2010. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials. 31:3657–3666.
   PubMed Web of Science ®Google Scholar
• Herneisey M, Williams J, Mirtic J, Liu L, Potdar S, Bagia C, Cavanaugh JE, Janjic JM. 2016. Development and characterization of resveratrol nanoemulsions carrying dual-imaging agents. Ther Deliv. 7:795–808.
   PubMed Web of Science ®Google Scholar
• Hitchens TK, Ye Q, Eytan DF, Janjic JM, Ahrens ET, Ho C. 2011. 19F MRI detection of acute allograft rejection with in vivo perfluorocarbon labeling of immune cells. Magn Reson Med. 65:1144–1153.
   PubMed Web of Science ®Google Scholar
• Hormann K, Zimmer A. 2016. Drug delivery and drug targeting with parenteral lipid nanoemulsions - A review. J Control Release. 223:85–98.
   PubMed Web of Science ®Google Scholar
• Igne B, Shi Z, Drennen JK, 3rd, Anderson CA. 2014. Effects and detection of raw material variability on the performance of near-infrared calibration models for pharmaceutical products. J Pharm Sci. 103:545–556.
   PubMed Web of Science ®Google Scholar
• Ikomi F, Hanna GK, Schmid-Schönbein GW. 1999. Size- and surface-dependent uptake of colloid particles into the lymphatic system [Article]. Lymphology. 32:90–102.
   PubMed Web of Science ®Google Scholar
• Janjic JM, Ahrens ET. 2009. Fluorine-containing nanoemulsions for MRI cell tracking. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 1:492–501.
   PubMed Web of Science ®Google Scholar
• Janjic JM, Shao P, Zhang S, Yang X, Patel SK, Bai M. 2014. Perfluorocarbon nanoemulsions with fluorescent, colloidal and magnetic properties. Biomaterials. 35:4958–4968.
   PubMed Web of Science ®Google Scholar
• Janjic JM, Srinivas M, Kadayakkara DK, Ahrens ET. 2008. Self-delivering nanoemulsions for dual fluorine-19 MRI and fluorescence detection. J Am Chem Soc. 130:2832–2841.
   PubMed Web of Science ®Google Scholar
• Kadayakkara DK, Beatty PL, Turner MS, Janjic JM, Ahrens ET, Finn OJ. 2010. Inflammation driven by overexpression of the hypoglycosylated abnormal mucin 1 (MUC1) links inflammatory bowel disease and pancreatitis. Pancreas. 39:510–515.
   PubMed Web of Science ®Google Scholar
• Kamboj S, Rana V. 2016. Quality-by-design based development of a self-microemulsifying drug delivery system to reduce the effect of food on Nelfinavir mesylate. Int J Pharm. 501:311–325.
   PubMed Web of Science ®Google Scholar
• Kaufman RJ, Richard TJ, inventors. 1992. Emulsions of highly fluorinated organic compounds, assignee. HemaGen/PFC. U.S. Patent 5,171,755.
   Google Scholar
• Kaur R, Garg T, Das Gupta U, Gupta P, Rath G, Goyal AK. 2015. Preparation and characterization of spray-dried inhalable powders containing nanoaggregates for pulmonary delivery of anti-tubercular drugs. Artif Cells Nanomed Biotechnol. 1:6.
   Google Scholar
• Kim HW, Greenburg AG. 2004. Artificial oxygen carriers as red blood cell substitutes: a selected review and current status. Artif Organs. 28:813–828.
   PubMed Web of Science ®Google Scholar
• Kim HW, Greenburg AG. 2006. Toward 21st century blood component replacement therapeutics: artificial oxygen carriers, platelet substitutes, recombinant clotting factors, and others. Artif Cells Blood Substit Immobil Biotechnol. 34:537–550.
   PubMed Web of Science ®Google Scholar
• Klang V, Valenta C. 2011. Lecithin-based nanoemulsions. J Drug Deliv Sci Technol. 21:55–76.
   Web of Science ®Google Scholar
• Kotta S, Khan AW, Pramod K, Ansari SH, Sharma RK, Ali J. 2012. Exploring oral nanoemulsions for bioavailability enhancement of poorly water-soluble drugs. Expert Opin Drug Deliv. 9:585–598.
   PubMed Web of Science ®Google Scholar
• Krafft MP, Riess JG. 1998. Highly fluorinated amphiphiles and colloidal systems, and their applications in the biomedical field. A contribution. Biochimie. 80:489–514.
   PubMed Web of Science ®Google Scholar
• Krafft MP, Riess JG. 2009. Chemistry, physical chemistry, and uses of molecular fluorocarbon-hydrocarbon diblocks, triblocks, and related compounds-unique “apolar” components for self-assembled colloid and interface engineering. Chem Rev. 109:1714–1792.
   PubMed Web of Science ®Google Scholar
• Krafft MP, Riess JG. 2015. Selected physicochemical aspects of poly- and perfluoroalkylated substances relevant to performance, environment and sustainability-part one. Chemosphere. 129:4–19.
   PubMed Web of Science ®Google Scholar
• Lanza GM, Winter PM, Caruthers SD, Hughes MS, Hu G, Schmieder AH, Wickline SA. 2010. Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions. Angiogenesis. 13:189–202.
   PubMed Web of Science ®Google Scholar
• Lanza GM, Yu X, Winter PM, Abendschein DR, Karukstis KK, Scott MJ, Chinen LK, Fuhrhop RW, Scherrer DE, Wickline SA. 2002. Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis. Circulation. 106:2842–2847.
   PubMed Web of Science ®Google Scholar
• Liu L, Bagia C, Janjic JM. 2015. The first scale-up production of theranostic nanoemulsions. Biores Open Access. 4:218–228.
   PubMed Web of Science ®Google Scholar
• Lowe KC. 1999. Perfluorinated blood substitutes and artificial oxygen carriers. Blood Rev. 13:171–184.
   PubMed Web of Science ®Google Scholar
• McClements DJ. 2012. Nanoemulsions versus microemulsions: Terminology, differences, and similarities. Soft Matter. 8:1719–1729.
   Web of Science ®Google Scholar
• McClements DJ, Rao J. 2011. Food-grade nanoemulsions: formulation, fabrication, properties, performance, biological fate, and potential toxicity. Crit Rev Food Sci Nutr. 51:285–330.
   PubMed Web of Science ®Google Scholar
• Mitri K, Vauthier C, Huang N, Menas A, Ringard-Lefebvre C, Anselmi C, Stambouli M, Rosilio V, Vachon JJ, Bouchemal K. 2012. Scale-up of nanoemulsion produced by emulsification and solvent diffusion. J Pharm Sci. 101:4240–4247.
   PubMed Web of Science ®Google Scholar
• Mountain GA, Jelier BJ, Bagia C, Friesen CM, Janjic JM. 2014. Design and formulation of nanoemulsions using 2-(poly(hexafluoropropylene oxide)) perfluoropropyl benzene in combination with linear perfluoro(polyethylene glycol dimethyl ether). J Fluor Chem. 162:38–44.
   PubMed Web of Science ®Google Scholar
• Muller RH, Harden D, Keck CM. 2012. Development of industrially feasible concentrated 30% and 40% nanoemulsions for intravenous drug delivery. Drug Dev Ind Pharm. 38:420–430.
   PubMed Web of Science ®Google Scholar
• O'Hanlon CE, Amede KG, O'Hear MR, Janjic JM. 2012. NIR-labeled perfluoropolyether nanoemulsions for drug delivery and imaging. J Fluor Chem. 137:27–33.
   PubMed Web of Science ®Google Scholar
• Onodera T, Kuriyama I, Andoh T, Ichikawa H, Sakamoto Y, Lee-Hiraiwa E, Mizushina Y. 2015. Influence of particle size on the in vitro and in vivo anti-inflammatory and anti-allergic activities of a curcumin lipid nanoemulsion. Int J Mol Med. 35:1720–1728.
   PubMed Web of Science ®Google Scholar
• Patel SK. 2015. Macrophage COX-2 as a target for imaging and therapy of inflammatory diseases using theranostic nanoemulsions [dissertation]. ProQuest: Duquesne University.
   Google Scholar
• Patel SK, Beaino W, Anderson CJ, Janjic JM. 2015. Theranostic nanoemulsions for macrophage COX-2 inhibition in a murine inflammation model. Clin Immunol. 160:59–70.
   PubMed Web of Science ®Google Scholar
• Patel SK, Janjic JM. 2015. Macrophage targeted theranostics as personalized nanomedicine strategies for inflammatory diseases. Theranostics. 5:150–172.
   PubMed Web of Science ®Google Scholar
• Patel SK, Patrick MJ, Pollock JA, Janjic JM. 2013a. Two-color fluorescent (near-infrared and visible) triphasic perfluorocarbon nanoemuslions. J Biomed Opt. 18:101312.
   PubMed Web of Science ®Google Scholar
• Patel SK, Zhang Y, Pollock JA, Janjic JM. 2013b. Cyclooxgenase-2 inhibiting perfluoropoly (ethylene glycol) ether theranostic nanoemulsions-in vitro study. PLoS One. 8:e55802.
   PubMed Web of Science ®Google Scholar
• Patel V, Agrawal Y. 2011. Nanosuspension: an approach to enhance solubility of drugs. J Adv Pharm Tech Res. 2:81–87.
   PubMedGoogle Scholar
• Pharmaceutical Development Q8(R2). 2009. U.S. Food and Drug Administration; [accessed 04/26/2018]. https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q8_R1/Step4/Q8_R2_Guideline.pdf.
   Google Scholar
• Pund S, Shete Y, Jagadale S. 2014. Multivariate analysis of physicochemical characteristics of lipid based nanoemulsifying cilostazol-quality by design. Colloids Surf B Biointerfaces.. 115:29–36.
   PubMed Web of Science ®Google Scholar
• Rajpoot P, Pathak K, Bali V. 2011. Therapeutic applications of nanoemulsion based drug delivery systems: a review of patents in last two decades. Recent Pat Drug Deliv Formul. 5:163–172.
   PubMedGoogle Scholar
• Rapoport N, Nam K-H, Gupta R, Gao Z, Mohan P, Payne A, Todd N, Liu X, Kim T, Shea J, et al. 2011. Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions. J Control Release. 153:4–15.
   PubMed Web of Science ®Google Scholar
• Riess JG. 2002. Fluorous micro- and nanophases with a biomedical perspective. Tetrahedron. 58:4113–4131.
   Web of Science ®Google Scholar
• Riess JG. 2005. Fluorous materials for biomedical uses. In: Gladysz JA, Curran DP, Horvath IT, editors. Handbook of fluorous chemistry. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA; p. 521–561.
   Google Scholar
• Riess JG, Krafft MP. 1998. Fluorinated materials for in vivo oxygen transport (blood substitutes), diagnosis and drug delivery. Biomaterials. 19:1529–1539.
   PubMed Web of Science ®Google Scholar
• Sarker DK. 2005. Engineering of nanoemulsions for drug delivery. Curr Drug Deliv. 2:297–310.
   PubMedGoogle Scholar
• Schweighardt FK, Kayhart CR, inventors. 1990. Concentrated stable fluorochemical aqueous emulsions containing trigylcerides, assignee. Versum Materials US, LLC. U.S. Patent 4,895,876.
   Google Scholar
• Shakeel F, Shafiq S, Haq N, Alanazi FK, Alsarra IA. 2012. Nanoemulsions as potential vehicles for transdermal and dermal delivery of hydrophobic compounds: an overview. Expert Opin Drug Deliv. 9:953–974.
   PubMed Web of Science ®Google Scholar
• Shaw SY, Westly EC, Pittet MJ, Subramanian A, Schreiber SL, Weissleder R. 2008. Perturbational profiling of nanomaterial biologic activity. Proc Natl Acad Sci USA. 105:7387–7392.
   PubMed Web of Science ®Google Scholar
• Snee RD, Hoerl RW, Bucci G. 2016. A statistical engineering strategy for mixture problems with process variables. Qual Eng. 28:263–279.
   Web of Science ®Google Scholar
• Spahn DR. 1999. Blood substitutes. Artificial oxygen carriers: perfluorocarbon emulsions. Crit Care. 3:R93–R97.
   PubMed Web of Science ®Google Scholar
• Srinivas M, Turner MS, Janjic JM, Morel PA, Laidlaw DH, Ahrens ET. 2009. In vivo cytometry of antigen-specific t cells using 19F MRI. Magn Reson Med. 62:747–753.
   PubMed Web of Science ®Google Scholar
• Stoll G, Basse-Lusebrink T, Weise G, Jakob P. 2012. Visualization of inflammation using (19) F-magnetic resonance imaging and perfluorocarbons. Wires Nanomed Nanobiotechnol. 4:438–447.
   PubMed Web of Science ®Google Scholar
• Tsuda Y, Yamanouchi K, Okamoto H, Yokoyama K, Heldebrant C. 1990. Intravascular behavior of a perfluorochemical emulsion. J Pharmacobiodyn. 13:165–171.
   PubMedGoogle Scholar
• Wang W, Sedykh A, Sun H, Zhao L, Russo DP, Zhou H, Yan B, Zhu H. 2017. Predicting nano-bio interactions by integrating nanoparticle libraries and quantitative nanostructure activity relationship modeling. ACS Nano. 11:12641–12649.
   PubMed Web of Science ®Google Scholar
• Weers JG, Arlauskas RA, Tarara TE, Pelura TJ. 2004. Characterization of fluorocarbon-in-water emulsions with added triglyceride. Langmuir. 20:7430–7435.
   PubMed Web of Science ®Google Scholar
• Weise G, Basse-Luesebrink TC, Wessig C, Jakob PM, Stoll G. 2011. In vivo imaging of inflammation in the peripheral nervous system by (19)F MRI. Exp Neurol. 229:494–501.
   PubMed Web of Science ®Google Scholar
• Winter PM, Schmieder AH, Caruthers SD, Keene JL, Zhang H, Wickline SA, Lanza GM. 2008. Minute dosages of alpha(nu)beta3-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbits. Faseb J. 22:2758–2767.
   PubMed Web of Science ®Google Scholar
• Xia F, Fan W, Jiang S, Ma Y, Lu Y, Qi J, Ahmad E, Dong X, Zhao W, Wu W. 2017. Size-dependent translocation of nanoemulsions via oral delivery. ACS Appl Mater Interfaces. 9:21660–21672.
   PubMed Web of Science ®Google Scholar